Total Payments
$14,491
2024 Payments
$1,084
Companies
40
Transactions
621
Medicare Patients
5,081
Medicare Billing
$729,391
Payment Breakdown by Category
Food & Beverage$11,024 (76.1%)
Research$3,226 (22.3%)
Education$240.76 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,024 | 615 | 76.1% |
| Unspecified | $3,226 | 1 | 22.3% |
| Education | $240.76 | 5 | 1.7% |
Payments by Type
General
$11,265
620 transactions
Research
$3,226
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| MAYNE PHARMA INC. | $5,372 | 191 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $1,065 | 48 | $0 (2024) |
| MAYNE PHARMA COMMERCIAL LLC | $959.93 | 71 | $0 (2024) |
| Lilly USA, LLC | $753.18 | 27 | $0 (2024) |
| ABBVIE INC. | $641.71 | 24 | $0 (2024) |
| Janssen Biotech, Inc. | $618.74 | 30 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $480.07 | 24 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $469.50 | 13 | $0 (2023) |
| PFIZER INC. | $417.52 | 20 | $0 (2023) |
| Amgen Inc. | $390.55 | 16 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,084 | 51 | MAYNE PHARMA COMMERCIAL LLC ($482.44) |
| 2023 | $1,993 | 86 | MAYNE PHARMA COMMERCIAL LLC ($477.49) |
| 2022 | $1,042 | 56 | MAYNE PHARMA INC. ($393.14) |
| 2021 | $958.53 | 48 | Lilly USA, LLC ($254.71) |
| 2020 | $1,004 | 65 | MAYNE PHARMA INC. ($316.05) |
| 2019 | $1,573 | 113 | Mayne Pharma Inc. ($482.73) |
| 2018 | $5,039 | 104 | Mayne Pharma Inc. ($3,756) |
| 2017 | $1,796 | 98 | Mayne Pharma Inc. ($282.75) |
All Payment Transactions
621 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Immunology | ||||||
| 12/17/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $13.94 | General |
| 12/12/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $16.28 | General |
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $108.17 | General |
| Category: Immunology | ||||||
| 11/19/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $18.10 | General |
| 11/12/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $14.48 | General |
| 10/29/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $16.22 | General |
| 10/24/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $37.02 | General |
| 10/22/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $14.48 | General |
| 10/15/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $14.29 | General |
| 10/01/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $15.23 | General |
| 09/05/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $25.47 | General |
| Category: Dermatology | ||||||
| 09/04/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $87.92 | General |
| Category: Immunology | ||||||
| 08/27/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.64 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $13.80 | General |
| 08/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.44 | General |
| Category: Immunology | ||||||
| 08/20/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $13.10 | General |
| 08/13/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $13.39 | General |
| 08/06/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $14.11 | General |
| 07/15/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $13.35 | General |
| 07/11/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $29.95 | General |
| 07/08/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $16.50 | General |
| 07/01/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $17.26 | General |
| 06/24/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $14.65 | General |
| 06/10/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $14.69 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Use of Fabior for keratoderma for psorisis | Mayne Pharma Inc. | $3,226 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,259 | 3,612 | $404,234 | $193,719 |
| 2022 | 17 | 1,235 | 3,445 | $359,929 | $166,284 |
| 2021 | 20 | 1,337 | 4,249 | $412,444 | $199,819 |
| 2020 | 15 | 1,250 | 3,969 | $399,179 | $169,570 |
Total Patients
5,081
Total Services
15,275
Medicare Billing
$729,391
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 275 | 523 | $128,135 | $65,362 | 51.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 261 | 421 | $78,306 | $35,217 | 45.0% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 171 | 242 | $46,222 | $24,591 | 53.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 121 | 254 | $33,274 | $16,524 | 49.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 125 | 165 | $24,090 | $9,813 | 40.7% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 40 | 50 | $22,000 | $9,420 | 42.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 74 | 97 | $15,811 | $8,340 | 52.7% |
| 95044 | Test for allergy using skin patch | Office | 2023 | 24 | 1,660 | $11,620 | $6,342 | 54.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 60 | 60 | $9,840 | $4,213 | 42.8% |
| 11604 | Removal of cancer skin growth of body, arms, or legs, 3.1-4.0 cm | Office | 2023 | 13 | 15 | $6,825 | $3,475 | 50.9% |
| 11643 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 2.1-3.0 cm | Office | 2023 | 11 | 11 | $5,071 | $2,542 | 50.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 36 | 63 | $4,599 | $2,448 | 53.2% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 15 | 16 | $7,360 | $2,096 | 28.5% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 19 | 21 | $8,547 | $2,074 | 24.3% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 14 | 14 | $2,534 | $1,262 | 49.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 252 | 435 | $108,855 | $53,772 | 49.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 248 | 386 | $73,580 | $31,981 | 43.5% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2022 | 136 | 169 | $33,444 | $17,372 | 51.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 129 | 222 | $29,939 | $14,254 | 47.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 129 | 166 | $25,382 | $9,701 | 38.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 96 | 109 | $18,403 | $9,170 | 49.8% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 32 | 43 | $19,562 | $8,133 | 41.6% |
| 95044 | Test for allergy using skin patch | Office | 2022 | 23 | 1,610 | $12,880 | $5,946 | 46.2% |
| 11604 | Removal of cancer skin growth of body, arms, or legs, 3.1-4.0 cm | Office | 2022 | 13 | 14 | $6,574 | $3,338 | 50.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 40 | 40 | $6,800 | $2,772 | 40.8% |
About Dr. Farooq Lateef, M.D
Dr. Farooq Lateef, M.D is a Specialist healthcare provider based in Orlando, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2007. The National Provider Identifier (NPI) number assigned to this provider is 1982802823.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Farooq Lateef, M.D has received a total of $14,491 in payments from pharmaceutical and medical device companies, with $1,084 received in 2024. These payments were reported across 621 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($11,024).
As a Medicare-enrolled provider, Lateef has provided services to 5,081 Medicare beneficiaries, totaling 15,275 services with total Medicare billing of $729,391. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Orlando, FL
- Active Since 07/03/2007
- Last Updated 05/22/2024
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1982802823
Products in Payments
- FABIOR (Drug) $3,226
- DORYX (Drug) $1,612
- COSENTYX (Biological) $809.11
- TREMFYA (Drug) $745.25
- TALTZ (Drug) $590.01
- EUCRISA (Drug) $417.52
- Sotyktu (Drug) $368.34
- VTAMA (Drug) $366.73
- Otezla (Drug) $328.91
- Winlevi (Drug) $272.05
- Humira (Biological) $250.05
- Enbrel (Biological) $224.07
- ENSTILAR (Drug) $209.30
- COSENTYX (Drug) $165.80
- OLUMIANT (Drug) $163.17
- RINVOQ (Biological) $161.19
- ILUMYA (Biological) $143.10
- DUPIXENT (Biological) $135.24
- KERYDIN (Drug) $130.88
- DUPIXENT (Drug) $125.90
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Orlando
Dr. Peter Wearden, Md,Phd, MD,PHD
Specialist — Payments: $60,944
Specialist $60,944
Dr. Anthony Rongione, M.d, M.D
Specialist — Payments: $39,392
Specialist $39,392
Augustine Joseph, Md, MD
Specialist — Payments: $25,257
Specialist $25,257
Michael Anderson, M.d, M.D
Specialist — Payments: $23,459
Specialist $23,459
George Pope, M.d, M.D
Specialist — Payments: $17,863
Specialist $17,863
Dr. Muhammad Jawad, M.d, M.D
Specialist — Payments: $16,793
Specialist $16,793